ACE OncoCast
The official podcast feed of ACE Oncology. ACE provides evidence-based, high-quality independent medical education solutions that support clinicians in making up-to-date, appropriate treatment decisions. Listen to discussions among experts and stay informed on new data and best practices in the care of patients with cancer. The information in this podcast is provided for informational and educational purposes only.
ACE OncoCast
Targeted Therapy in Early-Stage EGFR-Mutated NSCLC
•
ACE Oncology
•
Season 5
•
Episode 1
In this episode, lung cancer experts discuss the treatment approach for patients with early-stage, resectable NSCLC who harbor EGFR sensitizing mutations. Listen to the latest clinical trial data on the use of adjuvant targeted therapy for this patient population.